Timeline · since 2015

Inter Pharm history

Dated record of real events — founding, the first distribution agreements, regulatory approvals, and certifications that form the current Inter Pharm distribution portfolio.

1. 2015

   16 March 2015

   Inter Pharm founded

   Inter Pharm D.O.O. registered in Podgorica at Vojina Katnića 4. Tax ID 03036944.

2. 2015–2018

   First distribution agreements

   Global medical-device brands enter Montenegro

   Inter Pharm signs the first distribution agreements with global medical-device manufacturers — interventional cardiology, microbiology, and surgery as the first clinical specialties covered.

3. 2019–2021

   Portfolio expansion

   Coverage reaches all key clinical specialties

   The distribution portfolio expands to orthopaedics, transfusion medicine, anaesthesia, aesthetic medicine, and other specialties — with a complete set of manufacturer authorisation letters for every brand.

4. 2020–2022

   SARS-CoV-2 portfolio

   Complete pandemic diagnostics

   During the SARS-CoV-2 pandemic Inter Pharm supplied a complete diagnostic pack: rapid antigen tests (Coris BioConcept, Vircell, Operon) and automated PCR detection (Cepheid GeneXpert).

5. 2023

   24 March 2023

   CInMED wholesale licence (2050/22/482/2-6492)

   The Agency for Medicines and Medical Devices of Montenegro issues the wholesale-of-medicines-and-medical-devices licence number 2050/22/482/2-6492, with cold-chain authorisation.

6. 2024

   ISO certification

   ISO 9001:2015 and ISO 14001:2015

   Inter Pharm secures ISO 9001:2015 (certificate 24-A-2817 Rev.0) and ISO 14001:2015 (certificate 24-C-1576 Rev.0) — quality-management and environmental-management systems. Issued by Global Inter Certification (IAS-accredited, MSCB-108); publicly verifiable through IAFCertSearch.

7. 2026

   Today

   Global medical catalogue across Montenegro

   Inter Pharm actively supplies the Clinical Centre of Montenegro and all seven regional general hospitals, plus private clinics and pharmacies across Montenegro. Forward-looking plan: Serbia coverage.